Pontillo G, Prados F, Wink AM, Kanber B, Bisecco A, Broeders TAA, Brunetti A, Cagol A, Calabrese M, Castellaro M, Cocozza S, Colato E, Collorone S, Cortese R, De Stefano N, Douw L, Enzinger C, Filippi M, Foster MA, Gallo A, Gonzalez-Escamilla G, Granziera C, Groppa S, Harbo HF, Høgestøl EA et al. (2025)
More Than the Sum of Its Parts: Disrupted Core Periphery of Multiplex Brain Networks in Multiple Sclerosis
Hum Brain Mapp, 46 (1), e70107
DOI 10.1002/hbm.70107, PubMed 39740239

Rød BE, Høgestøl EA, Torkildsen Ø, Bjørnevik K, Gran JM, Øverås MH, König M, Myhr KM, Wergeland S, Nygaard GO (2025)
Comparative effectiveness of rituximab and cladribine in relapsing-remitting multiple sclerosis: A target trial emulation
Mult Scler, 13524585251342727 (in press)
DOI 10.1177/13524585251342727, PubMed 40415655

Skattebøl L, Nygaard GO, Leonardsen EH, Kaufmann T, Moridi T, Stawiarz L, Ouellette R, Ineichen BV, Ferreira D, Muehlboeck JS, Beyer MK, Sowa P, Manouchehrinia A, Westman E, Olsson T, Celius EG, Hillert J, Kockum I, Harbo HF, Piehl F, Granberg T, Westlye LT, Høgestøl EA (2025)
Brain age in multiple sclerosis: a study with deep learning and traditional machine learning
Brain Commun, 7 (3), fcaf152
DOI 10.1093/braincomms/fcaf152, PubMed 40337466